Sai Zhang Bryak

Sai Zhang Bryak is a highly skilled scientist specializing in large molecule bioanalysis and cell therapy, currently serving as a Senior Scientist at WuXi AppTec since July 2023. Previously, at Thermo Fisher Scientific, Sai Zhang held the position of Scientist II, where expertise was applied in developing novel potency assays for multiple cell therapy products in compliance with cGMP standards. As a Postdoctoral Researcher at Rutgers Cancer Institute of New Jersey, research focused on identifying T cell clones with therapeutic potential for lung cancer patients. Sai Zhang also demonstrated significant findings regarding the regulation of the transcription factor PLZF during a Ph.D. program in Immunology at Rutgers University. Earlier professional experience includes managing operations at Bryak & Associates Law Firm and earning a Bachelor of Science in Pharmaceutical Sciences from China Pharmaceutical University.